Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
As of today, Molina Healthcare, Inc. has a stock rating of 6 (out of 10), which is considered Good.
As of today, Molina Healthcare, Inc. has a Good stock rating, which is 37.0% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.